logo
HSBC cuts rating of UnitedHealth, citing earnings risks amid CEO shake-up

HSBC cuts rating of UnitedHealth, citing earnings risks amid CEO shake-up

Yahoo21-05-2025
Investing.com - UnitedHealth Group (NYSE:UNH) faces risks to earnings growth despite a recent leadership shake-up, analysts at HSBC said in a note to clients downgrading their rating of the healthcare insurer.
Shares in UnitedHealth, which have fallen sharply since the company announced an executive-level change and pulled its 2025 guidance earlier this month, were lower by more than 1% in premarket U.S. trading on Wednesday.
The company said it had suspended its full-year financial forecast due to a bigger-than-anticipated spike in medical costs, while CEO Andrew Witty has decided to step down from the role.
In a statement, UnitedHealth said Witty's departure was due to personal reasons. Stephen Hemsley was appointed as Witty's successor.
Hemsley, who previously served as CEO from 2006 to 2017, will also remain Chairman. Witty will be a senior adviser to Hemsley, UnitedHealth added.
Witty had overseen a tumultuous time for the firm, particularly after the shooting death late last year of Brian Thompson, who led its insurance arm. Earlier this month, UnitedHealth was sued by shareholders for allegedly covering up how the killing had impacted its operations.
Meanwhile, UnitedHealth said it had halted its 2025 outlook, citing higher-than-estimated medical expenses related to many new beneficiaries from government-backed Medicare Advantage plans for older adults. Care activity has continued to accelerate and broaden out to "more types of benefit offerings than seen in the first quarter", the firm noted.
Like other health insurance providers, UnitedHealth has been grappling with an uptick in medical costs as more people with Medicare plans choose to go ahead with elective surgeries previously delayed during the pandemic. Its Optum Health division, which houses the prescription drug plans it runs for Medicare, has also faced pressure from patients needing more care.
"The downside risk on 2025 estimated adjusted earnings per share has increased post guidance cancellation, giving the new CEO a kitchen sinking opportunity," the HSBC analysts led by Sidharth Sahoo said. "We also see potential recovery getting delayed [...]"
The brokerage subsequently slashed its rating of UnitedHealth to "reduce" from "hold" and lowered its price target by around 45% to $270. On Tuesday, the stock ended trading at $312.58.
Related articles
HSBC cuts rating of UnitedHealth, citing earnings risks amid CEO shake-up
UnitedHealth Group shares drop on report of secret nursing home payments
BofA sees rising China risk for EU tech firms as domestic shift deepens
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Monthly Dividend Calendar: How The Ultra Wealthy Build Cash Machines
The Monthly Dividend Calendar: How The Ultra Wealthy Build Cash Machines

Forbes

time18 minutes ago

  • Forbes

The Monthly Dividend Calendar: How The Ultra Wealthy Build Cash Machines

Sources of Wealth Warren Buffett's enduring wisdom rings especially true for America's wealthiest families: "Someone is sitting in the shade today because someone planted a tree a long time ago." For family offices managing generational wealth, this philosophy translates into sophisticated income strategies that prioritize decades over quarters and increasingly, that means embracing the monthly dividend calendar. Unlike retail investors who might check their portfolios sporadically, ultra-high-net-worth families face relentless monthly obligations. Private jet maintenance, philanthropic commitments, estate management, and don't pause for quarterly earnings reports. These families need predictable, consistent cash flow which explains why family offices overseeing $50 million to $500 million are quietly revolutionizing their approach to dividend investing. Engineering Monthly Income Streams The concept is elegantly simple yet remarkably powerful: construct a portfolio of 24 carefully selected dividend-paying stocks, with two companies distributing payments each month. The result? A synthetic salary that arrives as reliably as clockwork, without ever selling a single share. This systematic approach delivers three critical advantages for wealthy families. First, it provides reliable liquidity to fund lifestyle expenses and philanthropic initiatives. Second, qualified dividends receive favorable tax treatment compared to ordinary income. Third, the strategy enables portfolio compounding without forced liquidations that could disrupt long-term wealth accumulation. Consider this sample monthly dividend calendar, featuring blue-chip stalwarts and Dividend Aristocrats: January: Brookfield Infrastructure (BIPC) and Nike (NKE)February: Procter & Gamble (PG) and AbbVie (ABBV)March: Realty Income (O) and McDonald's (MCD)April: Verizon (VZ) and Altria (MO)May: Chevron (CVX) and Apple (AAPL)June: Microsoft (MSFT) and UnitedHealth (UNH)July: Coca-Cola (KO) and Dollar General (DG)August: Lockheed Martin (LMT) and Charles Schwab (SCHW)September: Waste Management (WM) and Deere & Co (DE)October: Canadian National Railway (CNI) and Sysco (SYY)November: Amgen (AMGN) and Citigroup (C)December: ExxonMobil (XOM) and T-Mobile (TMUS) These aren't speculative yield plays they're fortress-like businesses with decades-long track records of dividend growth and reliability. The Blue Owl Advantage Among alternative asset managers capturing family office attention, Blue Owl Capital (NYSE: OWL) stands out as a compelling case study in modern dividend strategy. Since going public in 2021, this alternative asset management powerhouse has delivered consistent quarterly distributions while building a business model specifically designed for income reliability. Blue Owl's appeal lies in its focus on permanent capital strategies, including direct lending and GP stakes, which generate durable cash flows across market cycles. Currently yielding approximately 3.9%, the company's dividend is backed by strong recurring revenue streams from management and advisory fees creating what amounts to a cash flow machine for shareholders. For family offices seeking alternatives to traditional fixed-income investments, Blue Owl represents a new breed of dividend-paying companies: those that combine the reliability of utility-like payouts with superior growth prospects and inflation protection. Strategic Advantages for Ultra-Wealthy Families The monthly dividend strategy addresses several unique challenges facing family offices. Most importantly, it synchronizes investment income with monthly outflows, eliminating the cash management headaches that come with quarterly or annual dividend payments. This approach also minimizes the wealth-eroding effect of holding excessive idle capital in low-yielding money market accounts. By keeping capital productively invested while generating monthly income, families can maintain their purchasing power against inflation while preserving long-term growth potential. Perhaps most valuable is the optionality that monthly income provides. Regular cash flow creates opportunities for tactical reinvestment, private market commitments, or opportunistic acquisitions without disrupting core portfolio positions. Avoiding Common Pitfalls Even sophisticated investors can stumble when implementing dividend strategies. The most dangerous mistake is chasing yield at the expense of quality such as prioritizing current income over dividend sustainability. Similarly, overconcentration in high-yielding sectors like REITs or utilities can create dangerous sector exposure. Smart family offices focus on dividend safety metrics, particularly payout ratios and free cash flow coverage. They also prioritize companies with dividend growth potential, recognizing that static payouts become wealth-destroying in inflationary environments. The Compounding Revolution Building a dividend-focused portfolio isn't about market timing or alpha generation, it's about creating a self-sustaining income engine that reduces dependence on asset sales. Over time, as dividends grow and compound, this strategy creates what Buffett might call "financial shade" protection from market volatility, liquidity constraints, and economic uncertainty. For America's wealthiest families, the monthly dividend calendar represents more than an investment strategy. It's a cash flow system, a liquidity solution, and a wealth preservation philosophy rolled into one elegant approach. As traditional bond yields remain suppressed and market volatility persists, this time-tested strategy is gaining momentum among those who understand that true wealth isn't just about accumulation it's about sustainable income generation that can support families for generations. The tree that Warren Buffett referenced isn't just growing, it's bearing fruit every single month.

How is the Dow calculated? Here's a breakdown.
How is the Dow calculated? Here's a breakdown.

Yahoo

time34 minutes ago

  • Yahoo

How is the Dow calculated? Here's a breakdown.

The Dow Jones Industrial Average (DJI) is an index comprised of 30 stocks. Because of its structure, it doesn't always trade in sync with other indexes like the S&P 500 (GSPC) and Nasdaq Composite (IXIC). In the video above, Stocks in Translation Host Jared Blikre explains how the Dow works. To watch more expert insights and analysis on the latest market action, check out more Stocks in Translation here. Today in Stocks and Translation, we're gonna take a look at how the Dow is actually calculated. Now, the Dow was born all the way back in 1896, nearly 130 years ago, before computers, before calculators, so this index of 30 stocks had to be easy to calculate. And for sake of simplicity, only the stock prices used. So the higher the stock price, the greater the weight in the index. And almost every other index, by the way, like the S&P and the Nasdaq, they use a company's market capitalization, but that gives that requires a lot more paperwork and more calculations. So here's the full method. Basically, you sum the prices of all 30 stocks in the index, and then you divide it by a number called the Dow divisor, which corrects for splits and changes in the components of the stocks. So anytime a stock has a stock split in the index, or when one stock is swapped out for another one, that Dow divisor will change. Now, here is a list of the four top stocks by price. Goldman Sachs is right at the top, with $723.65 as of the close yesterday. Microsoft is number two, Caterpillar is number three, Home Depot is number four. Now, United Health has a stock price of about $267 today, but before, uh, just a few months ago, it topped out at about 600, so it actually would have been number two in this list, had it not seen such a big slide. And I went in, and I calculated what the Dow would look like with different configurations here. So the orange line right here, which terminates last, that is the actual Dow. And then when you take out United Health in ye yellow, you have that line up here. And then I also took out Salesforce, Merck, and then Apple, because those were some of the biggest losers this year by percentage terms. And what you end up with is is a material materially higher Dow price without these big drags in it. And some of them can be actually quite big. And I also did another calculation here. I took, uh, the Dow price-weighted, that's the normal price weighting in white here, and then I also calculated it by market cap, starting at the beginning of the year. And when you do it by market cap, and I'm just gonna kind of trace this out here, we actually saw a lot more volatility by the lows. And again, this just includes all 30 stocks. I'm not taking out United Health or any of them. I'm just doing a different alternate calculation. So more volatility with the market cap weight, uh, version that we saw this year. Now, to sum up all the results, here's the market cap weighted 2025 year-to-date return. That came in at 7.3%. The actual price weighted number that everybody uses is 5.4%, and then the Dow minus United Health, that came in all the way up to 9.3%. And then you can take out Salesforce and Merck, and the numbers keep going up, and by the time you take out Apple, you have a Dow that's up 12.4%, and that's more than double the actual return of 5% and change. So something to think about here, uh, there's no guarantee that the Dow will always be calculated like this, but after 130 years, maybe they're just not gonna change. Tune into Stocks and Translation podcast for more jargon-busting deep dives. New episodes can be found every Tuesday and Thursday on Yahoo Finance's website, or wherever you find your podcasts. Related Videos Fed meeting: Why holding rates steady would be the 'right call' Market is seeing 'pockets of speculation,' not 'excessive' froth Berkshire trims VeriSign stake, Novo Nordisk craters, PayPal falls Market's 'fuel' for further P/E expansion is 'nearing empty' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

UNH Guidance Shock Sends Shares Tumbling, CEO Promises 2026 Upswing
UNH Guidance Shock Sends Shares Tumbling, CEO Promises 2026 Upswing

Yahoo

timean hour ago

  • Yahoo

UNH Guidance Shock Sends Shares Tumbling, CEO Promises 2026 Upswing

July 29 - UnitedHealth Group (NYSE:UNH) shares slid 5% Tuesday after new leadership set a full?year adjusted earnings?per?share target well below analyst forecasts. The company now expects at least $16.00 in adjusted EPS for fiscal 2025, down sharply from the previously withdrawn guidance of $26.00$26.50. Warning! GuruFocus has detected 4 Warning Sign with UNH. That outlook trails the FactSet consensus of $20.64 and falls beneath investor expectations of $18.00$20.00. Still, comments on 2026 projections helped avert a steeper selloff: UnitedHealth forecasts a return to earnings growth next year. Stephen Hemsley, who took the reins as CEO after Andrew Witty's departure, told analysts he anticipates solid to moderate EPS gains in 2026, with growth accelerating in 2027 and beyond. For Q2, UnitedHealth reported adjusted EPS of $4.08 versus the $4.48 consensus, and revenue of $111.6 billion, just above the $111.5 billion estimate. Executives pointed to pricing errors in managed?care plans, where medical costs outpaced projections, as the main drag on guidance this year. Investors will watch upcoming updates on cost controls and capital allocation as the company works to restore confidence and rebuild its market value. This article first appeared on GuruFocus.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store